Viewing Study NCT01007292


Ignite Creation Date: 2025-12-24 @ 3:32 PM
Ignite Modification Date: 2025-12-25 @ 1:50 PM
Study NCT ID: NCT01007292
Status: COMPLETED
Last Update Posted: 2015-10-19
First Post: 2009-09-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment
Sponsor: Astellas Pharma Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module